PlusDent, a Berlin-based health tech company, has received €35m from international investors to fund further expansion.
The Series C extension is led by Jebsen Capital, the investment division of the Hong Kong-based family business Jebsen Group, and one of the early investors in the German coronavirus vaccine manufacturer BioNTech. The existing investors also joined the round again.
World Cup star Mario Götze is also backing the startup in this financing round. The football-hero has just begun his very own PlusDent treatment.
Götze, said: “You would be hard pressed to find another German company that has been able to dominate the European market in such a short time. The incredible speed at which they’ve grown and their idea of both digitising dental treatments and making them available to everyone at a low cost immediately excited me.”
In previous financing rounds, the renowned investors: HV Capital, Lakestar, Cadence Growth Capital and Kreos Capital showed their enthusiasm by investing in PlusDent.
With the total amount invested close to €100 million, PlusDent is now one of the top four most invested-in med-tech startups in Germany, alongside BioNtech and Curevac.
“We already have a presence in eight European countries and will now accelerate our growth even further, especially in Spain, France and the UK,” announced Eva-Maria Meijnen, co-CEO of PlusDent.
PlusDent will launch its aligner treatments in Italy, Belgium and Denmark. Other countries will follow.
Meijnen, added: “We are well on our way to becoming Germany’s first female-led unicorn. By next year at the latest, that will be the case.”
But Meijnen is not only focusing on Europe; she also has her eyes set on China and will expand there this year.
“Hardly any other country welcomes new technologies as much as China. Now that we have an absolute dream team in Asia, with Ping An Global Voyager Fund and Jebsen Capital by our side, we will be able to give patients access to modern dentistry in this particularly exciting market,” said Meijnen.
The secret of this Berlin-based health tech company’s success? PlusDent works with the most successful dentists in Europe, and with their expertise, has digitised the entire dental correction process.
From making the appointment to planning the treatment, from follow-up to billing, each step is carried out on their self-developed digital dentistry platform. Every set of aligners is produced in the company’s own dental laboratory in Berlin, Germany, according to the latest medical standards and under the supervision of master dental technicians.
Today, around 200 dental practices in Germany, Austria, Switzerland, Great Britain, Spain, France, the Netherlands and Sweden already work with PlusDent. By the end of the year, this network will have grown to more than 500 partners.
More than 40,000 patients have already had a successful PlusDent treatment. The customer rating platform: ausgezeichnet, even commended PlusDent for having the highest patient trust among all companies in this field.
Just last year, the Chinese Ping An Global Voyager Fund joined PlusDent in a €32mfinancing round. Ping An is a technology-based financial services company and global market leader in telemedicine, operating the “Ping An Good Doctor” platform with over 700,000 digital doctor visits every day.
